ALLK: Allakos Inc. Stock

by  •  • Comments Off on ALLK: Allakos Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 28.86
Enterprise Value ($M) 11.10
Book Value ($M) 78.82
Book Value / Share 0.87
Price / Book 0.37
NCAV ($M) 67.80
NCAV / Share 0.75
Price / NCAV 0.43

Profitability (mra)
Return on Invested Capital (ROIC) -0.98
Return on Assets (ROA) -0.65
Return on Equity (ROE) -1.11

Liquidity (mrq)
Quick Ratio 4.81
Current Ratio 4.81

Balance Sheet (mrq) ($M)
Current Assets 85.59
Assets 96.60
Liabilities 17.78
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -118.76
Net Income -115.82
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -93.62
Cash from Investing 44.76
Cash from Financing 0.18

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
2 days ago 13D/A Tang Capital Management Llc 9.60 0.00
04-09 13G Beryl Capital Management LLC 8.90
11-12 13G Fmr Llc 6.04 279.40
07-08 13G/A BlackRock, Inc. 1.40 -75.23

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-17 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Mark One)
2025-03-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One)
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One)
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One)
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 176,431 1,855,845 9.51
2025-04-16 41,622 332,330 12.52
2025-04-15 72,492 1,155,352 6.27
2025-04-14 261,230 2,266,534 11.53

(click for more detail)

Similar Companies
AKRO – Akero Therapeutics, Inc. ALEC – Alector, Inc.
ALKS – Alkermes plc ALLO – Allogene Therapeutics, Inc.
ALNY – Alnylam Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io